DC Circ. Revives Cardinal Shipping Ban In Oxycodone Fight
The D.C. Circuit on Friday reinstated the ban blocking Cardinal Health Inc. prescription drug shipments brought on by allegations that it filled suspicious orders for oxycodone, saying the company hadn't demonstrated...To view the full article, register now.
Already a subscriber? Click here to view full article